- Home
- FENC vs CFFI Comparison
FENC vs CFFI Comparison
Compare FENC & CFFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FENC | CFFI |
|---|---|---|
| Founded | 1996 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.4M | 236.4M |
| IPO Year | 2010 | 1996 |
Fundamental Metrics
Financial Performance| Metric | FENC | CFFI |
|---|---|---|
| Price | $7.44 | $70.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 120.6K | 2.3K |
| Earning Date | 03-24-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.61% |
| EPS Growth | ★ 96.67 | 37.94 |
| EPS | N/A | ★ 8.29 |
| Revenue | $47,538,000.00 | ★ $140,841,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $70.78 | N/A |
| P/E Ratio | ★ N/A | $8.51 |
| Revenue Growth | ★ 123.69 | 10.63 |
| 52 Week Low | $4.68 | $53.14 |
| 52 Week High | $9.92 | $80.99 |
Technical Indicators
Market Signals| Indicator | FENC | CFFI |
|---|---|---|
| Relative Strength Index (RSI) | 41.25 | 49.15 |
| Support Level | $7.44 | $66.50 |
| Resistance Level | $8.19 | $79.63 |
| Average True Range (ATR) | 0.43 | 1.77 |
| MACD | -0.07 | -0.17 |
| Stochastic Oscillator | 11.79 | 58.37 |
Price Performance
Historical ComparisonAbout FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.